These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10659398)

  • 1. CJ 11974.
    Drugs R D; 1999 Oct; 2(4):241-2. PubMed ID: 10659398
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis.
    Hesketh PJ; Gralla RJ; Webb RT; Ueno W; DelPrete S; Bachinsky ME; Dirlam NL; Stack CB; Silberman SL
    J Clin Oncol; 1999 Jan; 17(1):338-43. PubMed ID: 10458252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MK 869. L 754030, MK 0869.
    Drugs R D; 1999 Oct; 2(4):249-50. PubMed ID: 10659402
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on new antiemetic drugs.
    Roila F; Tonato M; Ballatori E; Del Favero A
    J Clin Oncol; 1999 Jun; 17(6):1960-2. PubMed ID: 10561240
    [No Abstract]   [Full Text] [Related]  

  • 5. Itasetron. DAU 6215, U 98079.
    Drugs R D; 1999 Oct; 2(4):243-4. PubMed ID: 10659399
    [No Abstract]   [Full Text] [Related]  

  • 6. [Medical treatment of chemotherapy-induced nausea and vomiting].
    Herrstedt J
    Ugeskr Laeger; 2007 Feb; 169(9):799-805. PubMed ID: 17355844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomiting.
    Diemunsch P; Joshi GP; Brichant JF
    Br J Anaesth; 2009 Jul; 103(1):7-13. PubMed ID: 19454547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BNP-7787 (BioNumerik/Baxter Oncology/Grelan).
    Reilly RT
    IDrugs; 2004 Jan; 7(1):64-9. PubMed ID: 14730469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prophylaxis of chemotherapy-induced vomiting and nausea].
    Tóth J; Szántó J
    Magy Onkol; 2008 Dec; 52(4):391-4. PubMed ID: 19068468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IV aprepitant (Cinvanti) for chemotherapy-induced nausea and vomiting.
    Med Lett Drugs Ther; 2018 Dec; 60(1561):e200-e201. PubMed ID: 30653479
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neurokinin antagonists as antiemetics].
    Heinzl S
    Med Monatsschr Pharm; 2003 Oct; 26(10):336-7. PubMed ID: 14587153
    [No Abstract]   [Full Text] [Related]  

  • 12. [New, in Austria registered specialty drugs. Zofran (Ondansetron, Glaxo)].
    Erben M
    Wien Klin Wochenschr; 1991; 103(19):594-601. PubMed ID: 1836917
    [No Abstract]   [Full Text] [Related]  

  • 13. Palonosetron. RS 25259, RS 25259 197.
    Drugs R D; 1999 Oct; 2(4):251-2. PubMed ID: 10659403
    [No Abstract]   [Full Text] [Related]  

  • 14. [ECCO 2005. Advances in the prevention of chemotherapy-induced nausea and vomiting].
    Longo F; Mansueto G; Magnolfi E
    Tumori; 2006; 92(1):suppl 24-31. PubMed ID: 16683393
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice.
    Trigg ME; Higa GM
    J Oncol Pharm Pract; 2010 Dec; 16(4):233-44. PubMed ID: 20085961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why do we need another antiemetic? Just ask.
    Kris MG
    J Clin Oncol; 2003 Nov; 21(22):4077-80. PubMed ID: 14559888
    [No Abstract]   [Full Text] [Related]  

  • 18. State of the Art Antiemetic Therapy for Cancer Patients.
    Lau TK; Yip CH; Yeo W
    Curr Oncol Rep; 2016 Jan; 18(1):2. PubMed ID: 26694923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review.
    dos Santos LV; Souza FH; Brunetto AT; Sasse AD; da Silveira Nogueira Lima JP
    J Natl Cancer Inst; 2012 Sep; 104(17):1280-92. PubMed ID: 22911671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study design for the evaluation of the efficacy and safety of nabilone.
    Stark P
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():35-7. PubMed ID: 6299553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.